A study of European cities adds to a growing body of evidence that investments in cycling infrastructure can encourage bike commuting, which helps cut greenhouse gas emissions.
Tag: Research
Moderna and Pfizer-BioNTech Vaccines Are Very Effective, Report Says
Consistent with clinical trial data, a two-dose regimen prevented 90 percent of infections by two weeks after the second shot. One dose prevented 80 percent of infections by two weeks after vaccination.
Some Long Covid-19 Patients Feel Better After Vaccine Doses
It is too soon to tell whether the shots have a broad beneficial effect on patients with continuing issues, but scientists are intrigued and beginning to study the phenomenon.
Coronavirus Reinfections Are Rare, Danish Researchers Report
People over 65 are more likely to experience a second bout with the virus, according to a large study of medical records.
Some Long Covid Patients Feel Better After Getting the Vaccine
It is too soon to tell whether the shots have a broad beneficial effect on patients with continuing issues, but scientists are intrigued and beginning to study the phenomenon.
Moderna Begins Testing Its Covid Vaccine in Babies and Young Children.
The company plans to study healthy children ages six months through 11 years old in the U.S. and Canada.
Some Scientists Question W.H.O. Inquiry Into the Coronavirus Pandemic’s Origins
Those who still suspect the outbreak in China may have been caused by a lab leak or accident are pressing for an independent investigation.
Plan to Ditch the Mask After Vaccination? Not So Fast.
It’s not clear how easily vaccinated people may spread the virus, but the answer to that question is coming soon. Until then, scientists urge caution.
Virus Variant in Brazil Infected Many Who Had Already Recovered From Covid-19
The first detailed studies of the so-called P.1 variant show how it devastated a Brazilian city. Now scientists want to know what it will do elsewhere.
Virus Variant in Brazil Infected Many Who Had Already Recovered From Covid-19
The first detailed studies of the so-called P.1 variant show how it devastated a Brazilian city. Now scientists want to know what it will do elsewhere.